Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-509
Closed -$41K 149
2019
Q2
$41K Buy
509
+371
+269% +$28.4K 0.01% 80
2019
Q1
$11K Sell
138
-445
-76% -$33.3K ﹤0.01% 104
2018
Q4
$42K Buy
583
+33
+6% +$2.33K 0.01% 118
2018
Q3
$37K Buy
550
+3
+0.5% +$191 0.01% 130
2018
Q2
$32K Buy
547
+2
+0.4% +$113 0.01% 153
2018
Q1
$28K Sell
545
-117
-18% -$6.32K 0.01% 153
2017
Q4
$36K Buy
662
+431
+187% +$23.9K 0.01% 146
2017
Q3
$14K Sell
231
-424
-65% -$25.7K ﹤0.01% 137
2017
Q2
$40K Sell
655
-63
-9% -$3.83K 0.01% 132
2017
Q1
$44K Sell
718
-410
-36% -$24.9K 0.02% 125
2016
Q4
$66K Buy
+1,128
New +$66K 0.04% 110

Other funds holding MRK

Fusion Family Wealth's MRK Position: Q3 2019 in Review

Fusion Family Wealth sold out of Merck (MRK) in Q3 2019, closing a stake of 509 shares — an estimated $41K sold.

Fusion Family Wealth first reported a position in MRK in Q4 2016 and held it in 11 quarters. The position peaked at $66K in Q4 2016. 2,305 funds tracked by Wall St. Rank hold MRK as of Q3 2019.

  • Fusion Family Wealth reported no remaining Merck position as of Q3 2019 after selling out during the quarter.
  • Fusion Family Wealth sold 509 Merck shares in Q3 2019, an estimated $41K.
  • Fusion Family Wealth first reported a position in Merck in Q4 2016 and held it in 11 quarters.
  • Fusion Family Wealth's Merck position peaked at $66K in Q4 2016.
  • 2,305 funds tracked by Wall St. Rank held Merck as of Q3 2019.

Based on Fusion Family Wealth's 13F filing for Q3 2019, filed 31 Oct 2019.